Back to Journals » Therapeutics and Clinical Risk Management » Volume 12
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
21,180 | Dovepress* | 17,819+ | 1,892 | 19,711 | |
PubMed Central* | 3,361 | 366 | 3,727 | ||
Totals | 21,180 | 2,258 | 23,438 | ||
*Since 5 May 2016 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
16 | 0 | 0 | 1 | 7 | 8 |
View citations on PubMed Central and Google Scholar